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Since the 1970s, with the introduction of the Swan-Ganz catheter,(1) there 
has been significant progress in the capacity of invasive and non-invasive 
hemodynamic monitoring in intensive care units (ICU) and an improved 
understanding of the pathophysiological phenomena responsible for the 
hemodynamic instability of critical patients.
Despite these remarkable advances, there is no unanimity as to what 
therapeutic objectives should be achieved in patients with hemodynamic 
instability admitted to the ICU,(2) for the time being maintaining an individual 
therapeutic attitude guided not by hemodynamic monitoring data but by 
the integration of the different variables that can be obtained using multiple 
monitoring methods.
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Objective: To present a systematic 
review of the use of autonomic nervous 
system monitoring as a prognostic tool 
in intensive care units by assessing heart 
rate variability.
Methods: Literature review of 
studies published until July 2016 listed 
in PubMed/Medline and conducted 
in intensive care units, on autonomic 
nervous system monitoring, via analysis 
of heart rate variability as a prognostic 
tool (mortality study). The following 
English terms were entered in the search 
field: (“autonomic nervous system” OR 
“heart rate variability”) AND (“intensive 
care” OR “critical care” OR “emergency 
care” OR “ICU”) AND (“prognosis” 
OR “prognoses” OR “mortality”).
Results: There was an increased 
likelihood of death in patients who had 
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a decrease in heart rate variability as 
analyzed via heart rate variance, cardiac 
uncoupling, heart rate volatility, integer 
heart rate variability, standard deviation 
of NN intervals, root mean square 
of successive differences, total power, 
low frequency, very low frequency, 
low frequency/high frequency ratio, 
ratio of short-term to long-term fractal 
exponents, Shannon entropy, multiscale 
entropy and approximate entropy.
Conclusion: In patients admitted 
to intensive care units, regardless of the 
pathology, heart rate variability varies 
inversely with clinical severity and 
prognosis.
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This situation results from an overvaluation of 
our view of the cardiovascular system according to 
physics principles rather than a look at the capacity 
and adjustment of the real-time responses of critical 
patients to the pathophysiological changes induced by 
the disease and imposed by our therapeutic attitudes, 
either pharmacological or not. More important than 
the “normalization” of a given parameter is its temporal 
adjustment.
Recent studies(3-5) have described several hemodynamic 
monitoring methods, from the most invasive, such 
as the Swan-Ganz catheter, to the less invasive, such as 
bioimpedance and bioreactance methods. However, 
although the autonomic nervous system (ANS) is 
responsible for the homeostasis of the cardiocirculatory 
system through the balance between the activity of the 
sympathetic and parasympathetic ANS, no reference is 
made to the monitoring of its activity and/or its balance 
in ICU patients.
Heart rate variability (HRV) translates the oscillations 
in the duration of intervals between consecutive heart 
beats (NN intervals) (Figure 1) and is related to the 
influences of the ANS on the sinus node, translating the 
heart’s capacity to respond to multiple physiological and 
environmental stimuli, such as breathing, physical exercise, 
hemodynamic and metabolic changes, orthostatism and 
responses to stress induced by diseases. Moreover, the 
study of HRV of the ANS is only possible in the presence 
of sinus rhythm.
The objective of this article is to present a systematic 
review of studies involving autonomic nervous system 
monitoring of adult patients admitted to the intensive care 
units by analyzing the association of multiple heart rate 
variability assessment measures with the hospitalization 
outcome. Prospective and retrospective randomized 
controlled or cohort studies were included.
METHODS
In this systematic review, we used the checklist 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA)(6) as a guide to reach the 
standards accepted in systematic reviews.
The literature review of studies conducted in ICUs on 
ANS monitoring was conducted by searching all of the 
measures described for HRV analysis methods (Tables 1 
and 2) as a prognostic tool (mortality study), published 
in or before July 2016 (inclusive) using the PubMed/
MEDLINE database. The following English terms 
were entered in the search field, yielding 421 articles: 
(“autonomic nervous system” OR “heart rate variability”) 
AND (“intensive care” OR “critical care” OR “emergency 
care” OR “ICU”) AND (“prognosis” OR “prognoses” OR 
“mortality”).
After applying the filters to limit the studies to those 
involving humans aged over 19 years, without language 
restriction, 193 articles were excluded.
After reading the abstracts of the 228 selected studies, 
180 articles were excluded: 11 reported the monitoring of 
pediatric patients, 16 were conducted outside the intensive 
care setting, 119 were not related to ANS monitoring, 
four did not analyze HRV, 28 did not focus on prognosis 
and two were review studies.
The 48 articles selected were grouped and cataloged 
in EndNote® and were read in full. Afterwards, 32 
articles were excluded: 21 because they were not studies 
of ICU patients (11 were performed in the Emergency 
Department, five in the prehospital setting, two in 
the Cardiothoracic Surgery Service and two in the 
Figure 1 - Ten-second cardiotocogram showing heart rate variability.
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Table 1 - Methods for the study of heart rate variability(7-9)
1. Linear methods - time domain
a. Statistical measures
i. SDNN - Standard deviation of all normal NN intervals
ii. SDANN - Standard deviation of the average normal NN interval calculated over 5-minute intervals
iii. SDNNi - Mean of the standard deviations of all normal NN calculated over 5-minute intervals
iv. rMSSD - Square root of the mean squared differences of successive normal NN intervals
v. SDSD - Standard deviation of differences between adjacent normal NN intervals
vi. NN50 - Number of pairs of adjacent normal NN intervals differing by more than 50 milliseconds
vii. pNN50 - Percentage of normal NN intervals differing by more than 50 milliseconds from the adjacent interval
b. Geometric measures
i. Triangular index
ii. TINN - Triangular interpolation of normal NN intervals histogram
iii. Differential index
iv. Logarithmic index
2. Linear methods - frequency domain
a. Long-term analysis (5 minutes)
i. Total power
ii. VLF - Very low frequency
iii. LF - Low frequency
iv. LFn - Low frequency in normalized units
v. HF - High frequency
vi. HFn - High frequency in normalized units
vii. LF/HF - Low frequency/high frequency ratio 
b. Long-term analysis (24 hours)
i. Total power
ii. ULF - Ultra low frequency
iii. VLF - Very low frequency
iv. LF - Low frequency
v. HF - High frequency
vi. α - Slope of the linear interpolation of the spectrum in a logarithmic scale 
3. Time-frequency analysis methods
a. Time-varying parametric models
i. Autoregression models
b. Non-parametric methods
i. Short-time Fourier transform (STFT)




a. Detrended fluctuation analysis (total DTA, α1, α2 and α1/α2)
b. Correlation function 
c. Hurst exponent 
d. Fractal dimension 
e. Lyapunov exponent 
f. Sample entropy 
g. Multiscale entropy 
h. Approximate entropy (ApEn)
i. Shannon entropy
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Cardiology Service, and one study was conducted during 
the anesthetic period) and 11 because they did not report 
mortality data.
The references of the 16 selected articles were reviewed, 
and whenever there was reference to a new study, that 
study was evaluated; at the end of the review process, 18 
articles were selected (Figure 2).
Table 2 - Definition of measures for the study of heart rate variability in the time 
domain(7)
Measure Unit Definition
SDNN ms Standard deviation of all normal NN intervals
SDNNi ms Standard deviation of NN calculated over 5-minute 
intervals 
SDANN ms Standard deviation of the average NN interval 
rMSSD ms Root mean square of the successive NN interval difference
pNN50 % Normal-to-normal NN intervals whose difference exceeds 
50 milliseconds
Figure 2 - Article selection protocol.(6) HRV - heart rate variability; ICU - intensive care unit.
The quality of evidence for each selected study was 
assessed using the Methodological Index for Non-
Randomized Studies (MINORS) tool.(10)
The article review (data extraction and quality 
of evidence) was conducted by one author, with the 
information later independently verified by two others.
Table 3 shows the characteristics of the selected 
studies.
RESULTS
The 18 selected studies are presented in table 3. The 
type of study, study population, number of patients 
included, HRV variables studied in the ANS monitoring, 
most relevant conclusions and quality of evidence were 
also analyzed.
All studies reviewed were cohort, prospective 
or retrospective studies. The sample size was very 
heterogeneous, ranging from 18(11) to 2,178(12) patients; 
the sample size was not previously calculated in any 
study. The most studied pathology was trauma, mainly 
of the head, with a total of nine studies,(12-20) and with 
the same number of studies on patients with severe sepsis 
and septic shock,(21) multiple dysfunction syndrome,(22,23) 
patients undergoing therapeutic hypothermia after cardiac 
arrest,(11) with stroke(24) and neurosurgical patients;(25) three 
studies focused on the general population admitted to the 
ICU, without discriminating the reason for admission. 
The conclusions of all of the studies were obtained by 
comparing the groups according to the outcome evaluated, 
namely, mortality.
The results presented included increases in mortality 
associated with reduction in HRV (entropy 0.65 ± 0.24 
versus 0.84 ± 0.26; p < 0.05), reduction in the baroreflex 
(transfer function 0.43 ± 29 versus 1.11 ± 0.74; p < 0.05) 
and a sustained reduction of the low frequency/high 
frequency ratio (LF/HF ratio 0.22 ± 0.29 versus 0.62 ± 28; 
p < 0.01);(16) reductions in HRV, with odds ratios (ORs) of 
1.03(14) and of 1.035 - 1.052;(17) loss of heart rate volatility 
during the first 24 hours of hospitalization, translated as 
a coefficient of 0.05 in the logistic regression model (95% 
confidence interval [95% CI] 1.033 - 1.071);(18) integer 
heart rate variability (HRVi) with a sensitivity of 67% and 
a specificity of 91 - 100% to predict the mortality rate(13) 
or OR of 1.04;(15) and reduction in HRV in patients 
admitted to the ICU after cardiac arrest and undergoing 
therapeutic hypothermia, with a standard deviation of all 
normal NN intervals of 10.9 ± 4.1 versus 40.2 ± 19.5 (p = 
0.01) and a Shannon entropy of 2.2 ± 0.4 versus 3.7 ± 0.6 
(p = 0.008) for deceased versus surviving patients in the 
rewarming period. Concordant results were observed in 
the pre-hypothermia period.(11) There was also an increase 
in the parasympathetic tone as measured by the square 
root of the mean squared differences of successive intervals 
(rMSSD) (34.07 ± 6.54 versus 15.51 ± 3.90; p = 0.01) 
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Table 3 - Characteristics of the selected studies
Author Characteristics Evaluated outcomes Results
MINORS 
(score/total)
Pfeifer et al.(11) Prospective cohort study
Patients admitted to the ICU 
after cardiac arrest, subjected to 
therapeutic hypothermia
N = 18
28-day mortality There was a more pronounced reduction in 
HRV immediately after the rewarming phase 
in patients who died compared with survivors 
(SDNN 10.9 versus 40.2, Shannon entropy 2.2 
versus 3.7)
15/24
Riordan et al.(12) Retrospective cohort study
Multiple trauma patients admitted to 
the ICU
N = 2,178
Risk of death in the subgroups based 
on trauma location and mechanism 
and on probability of survival
Decreased MSE was significantly associated 
with increased mortality, being an independent 
factor of probability of survival in the multivariate 
analysis, with OR 0.87 - 0.94; the difference in 
median HR of MSE between survivors and non-
survivors was highest (15.9 versus 5.9) when the 
primary trauma mechanism was penetrating
10/24
Kahraman et al.(13) Prospective cohort study
Patients admitted to the ICU with head 
trauma with Glasgow coma scale 
score < 9 and need for ICP monitoring
N = 25
Capacity to predict intracranial 
hypertension, cerebral hypoperfusion, 
in-hospital mortality or functional 
outcome
HRVi* can predict in-hospital mortality, with a 
sensitivity of 67% and a specificity of 91-100%
15/24
Mowery et al.(14) Retrospective cohort study
Patients with head trauma and ICP 
monitoring
N = 145
Intracranial hypertension and mortality There is a relationship between percentage of 
ICP rise and cardiac decoupling with mortality. 
Each percentage increase had an increased risk 
of death of 1.04 and 1.03, respectively
15/24
Norris et al.(15) Retrospective cohort study
Trauma patients admitted to the ICU
N = 285
In-hospital mortality There was a decrease in HRV (increase in 
HRVi*), OR 1.04 ± 0.01 and MSE OR 0.88 ± 
0.03, in deceased patients
12/24





It was associated with increased mortality, 
reduced heart rate variability, reduced baroreflex 
sensitivity and sustained LF/HF ratio reduction
17/24
Norris et al.(17) Retrospective cohort study
Trauma patients admitted to the ICU
N = 2,088
Mortality Cardiac decoupling was associated with 
increased mortality OR 1.035 - 1.052
13/24
Grogan et al.(18) Retrospective cohort study
Trauma patients admitted to the ICU
N = 923
ICU mortality Patients with loss of heart rate volatility during 
the first 24 hours of hospitalization have a higher 
probability of death
10/24




Neurological recovery (Glasgow coma 
scale)
On the first post-trauma day, an increase in the 
parasympathetic tone (rMSSD and TP) may be 
associated with imminent brain death
17/24
Winchell et al.(20) Retrospective cohort study
Patients with severe head trauma
N = 80
Primary: in-hospital mortality and 
probability of discharge to the home
Secondary: CPP and ICP
Low HRV was associated with increased 
mortality; patients with a predominance of 
sympathetic activity and with a low HF/LF ratio 
had improved survival
16/24
Brown et al.(21) Prospective cohort study
Patients admitted to the ICU with 
severe sepsis or septic shock
N = 48
Primary outcome: suspension of 
vasoactive amines within the first 24 
hours of ICU admission
Secondary outcome: 28-day mortality
The ratio between short- and long-term fractal 
exponents was associated with 28-day mortality; 
all patients who died had ratios < 0.75
18/24
Schmidt et al.(22) Prospective cohort study
Patients with multiple organ 
dysfunction syndrome
N = 90
Analysis of survival at 180 and 365 
days
lnVLF† with a cutoff point of 3.9 was a strong 
predictor of 28-day and 2-month mortality 
in patients with multiple organ dysfunction 
syndrome
18/24
Schmidt et al.(23) Prospective cohort study
Patients with multiple dysfunction 
syndrome
N = 90
28-day mortality lnVLF† with a cut-off point of 3.9 was a strong 
predictor of 28-day mortality
20/24
Continue...
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Author Characteristics Evaluated outcomes Results
MINORS 
(score/total)
Gujjar et al.(24) Prospective cohort study
Acute stroke
N = 25
ICU mortality LFn was an independent predictor of survival, 
with a regression coefficient of -6.73 and an OR 
of 0.002
19/24
Haji-Michael et al.(25) Prospective cohort study
Neurosurgical patients with Glasgow 
coma scale score < 13
N = 29
3-month outcome Patients who died had decreased HRV, LF/HF 
ratio and baroreflex sensitivity
18/24
Papaioannou et al.(26) Prospective cohort study
General ICU population
N = 53
ICU mortality The minimum ApEn value correlated with 
mortality (r = 0.41; p = 0.01)
16/24
Yien et al.(27) Prospective cohort study
General population admitted for 
noncardiac causes
N = 52
Mortality Deceased patients had decreased VLF and LF 
band power
16/24
Winchell et al.(28) Prospective cohort study
General ICU population
N = 742
Mortality The relative risk of death in patients with low 
HRV was 7.4, with an increased HF/LF ratio of 
4.55
19/24
MINORS - Methodological Index for Non-Randomized Studies; ICU - intensive care unit; HRV - heart rate variability; MSE - multiscale entropy; OR - odds ratio; HR - hazard ratio; HRVi - integer 
heart rate variability; ICP - intracranial pressure; LF/HF - ratio between the low frequency component and the high frequency component; CPP - cerebral perfusion pressure; TP - total power. 
* Calculation of the standard deviation of the electrocardiogram signal collected every 1-4 seconds during a 5-minute interval; † natural logarithm of VLF.
... continuation
in patients with severe head injury;(19) decreased power 
in the low frequency band (low frequency in standard 
units in patients with severe stroke 18.90 ± 1.36 versus 
49.66 ± 2.10; p = 0.02; in the general population p < 0.05 
with Scheffé analysis);(24,27) decreased natural logarithm 
of the very low frequency band (lnVLF £ 3.9 with OR 
2.9; in the general population p < 0.05 with Scheffé 
analysis);(22,23,27,28) and decreased ratio of short- to long-
term fractal exponents; all patients admitted to the ICU 
with severe sepsis or septic shock who died had a ratio 
of < 0.75 (p = 0.04).(21) The following were also found: 
decreased multiscale entropy in trauma patients (8.9 
versus 16.6; p < 0.0001; 7.5 versus 11.2; p < 0.001 in 
patients with survival probabilities < 0.25; 7.7 versus 12.8; 
p < 0.01 for patients with survival probabilities of 0.25 to 
0.50; 9.4 versus 15.0; p < 0.001 for patients with survival 
probabilities of 0.50 to 0.75; 9.9 versus 16.1; and p < 
0.001 among those with survival probabilities ³ 0.75).(12,15) 
Decreased approximate entropy (mean ApEn 0.53 ± 0.25 
versus 0.62 ± 0.28; p = 0.04; minimum ApEn 0.24 ± 0.23 
versus 0.48 ± 0.23; p = 0.01) with a Pearson coefficient of 
0.41 (p = 0.01) was also found.(26)
Thus, these studies showed that, in patients admitted 
to the ICU, regardless of the pathology that led to 
hospitalization, HRV varied inversely with clinical severity 
and prognosis.(29)
DISCUSSION
The control of the cardiovascular system is ensured 
by the balance between the activity of the sympathetic 
ANS, which enervates the entire myocardium, and 
the parasympathetic ANS, which enervates the sinus 
node, the atrial myocardium and the atrioventricular 
node.(30) The influence of the ANS on the heart depends 
on the information it receives from the baroreceptors, 
chemoreceptors, atrial receptors, ventricular receptors, 
changes in the respiratory system, vasomotor system, renin-
angiotensin-aldosterone system and thermoregulatory 
system.(31) All of these influences condition the HRV, 
and the standards for its measurement, physiological 
interpretation and applicability were published in 1996.(7)
The HRV can be analyzed using different methods, 
with linear methods being the most used in clinical 
practice.
The time domain is analyzed using various measures 
and reflects the variation in the duration of NN intervals 
resulting from the depolarization of the sinus node.
Analysis of the frequency domain decomposes the 
HRV into the high frequency band, ranging between 
0.15 and 0.4 Hz, which corresponds to the respiratory 
modulation, translating the parasympathetic activity; the 
low frequency band, ranging between 0.04 and 0.15 Hz, 
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which corresponds to sympathetic and parasympathetic 
activity; the very low frequency band, ranging between 
0.003 and 0.04 Hz, which reflects the thermoregulation 
cycles; and ultra low frequency components, with 
variations below 0.003 Hz, modulated by the circadian 
rhythm and neuroendocrine axes.
The inverse relationship enters the very low frequency 
band, and the prognosis was first described in the 1960s,(32) 
when it was observed that NN interval reduction preceded 
fetal distress.
The first study conducted in the ICU was published in 
1996 and concluded that HRV reduction was related to 
increased mortality.(28) Since then, all studies conducted in 
the ICU have almost exclusively focused on the evaluation 
of HRV, which varies inversely with clinical severity and 
prognosis.(29)
Examples of clinical conditions in which HRV is 
predictive of patient survival include diabetes,(33) cancer,(34) 
heart failure,(35) acute myocardial infarction,(36) stroke,(37) 
epilepsy,(38) Parkinson’s disease(39) and kidney failure,(40) 
among others.
In patients admitted to the ICU, in addition to being 
used as a prognostic tool, HRV has also been described 
as a screening tool for multiple trauma patients,(41) as a 
tool for individual monitoring of organ dysfunction,(42) 
as a non-invasive tool for pain monitoring(43) and as an 
independent predictor factor for the prolongation of 
hospital stay in patients undergoing heart surgery(44) and 
has been used as a tool for successful extubation decision-
making.(45,46)
Some limitations were identified in the studies 
reviewed. There is no uniformity in the variables studied 
for HRV assessment, although the studies are concordant 
in the conclusions presented; furthermore, the quality of 
the evidence is low, due mainly to the sampled studies 
being cohort studies.
CONCLUSION
Heart rate variability occurs inversely to clinical 
severity and prognosis. The difficulty of introducing 
autonomic nervous system monitoring in the daily 
practice of intensive care units is due to the limitation of 
its use as a prognostic tool and, above all, to the difficulties 
involved in continuous and dynamic monitoring and in 
the interpretation and applicability of its results.
Successful implementation depends on heart rate 
variability monitoring going from a prognostic tool to 
a real-time monitoring instrument in order to be useful 
in therapeutic guidance; for example, as a guide for fluid 
therapy through analysis of the high frequency component 
and for treatment with vasoactive amines through analysis 
of the low frequency/high frequency ratio.
Objetivo: Apresentar uma revisão sistemática do uso da 
monitorização do sistema nervoso autônomo como ferramenta 
de prognóstico, verificando a variabilidade da frequência 
cardíaca nas unidades de cuidados intensivos.
Métodos: Revisão de literatura publicada até julho de 2016 
na PubMed/MEDLINE de estudos realizados em unidades 
de cuidados intensivos, sobre a monitorização do sistema 
nervoso autônomo, por meio da análise da variabilidade da 
frequência cardíaca, como ferramenta de prognóstico - estudo 
da mortalidade. Foram utilizados os seguintes termos em inglês 
no campo de pesquisa: (“autonomic nervous system” OR “heart 
rate variability”) AND (“intensive care” OR “critical care” OR 
“emergency care” OR “ICU”) AND (“prognosis” OR “prognoses” 
OR “mortality”).
Resultados: A probabilidade de morte nos doentes 
aumentou com a diminuição da variabilidade da frequência 
cardíaca, estudada por meio da variância da frequência cardíaca, 
desacoplamento cardíaco, volatilidade da frequência cardíaca, 
integer heart rate variability, desvio padrão de todos os intervalos 
RR normais, raiz quadrada da média do quadrado das diferenças 
entre intervalos RR adjacentes, poder total, componente de 
baixa frequência, componente de muito baixa frequência, razão 
entre o componente de baixa frequência e o componente de 
alta frequência), razão entre expoentes fractais de curto e longo 
prazo, entropia de Shannon, entropia multiescalar e entropia 
aproximada.
Conclusão: Nos doentes internados em unidades de cuidados 
intensivos, independentemente da patologia que motivou o 
internamento, a variabilidade da frequência cardíaca varia de 
forma inversa com a gravidade clínica e com o prognóstico.
RESUMO
Descritores: Sistema nervoso autônomo; Variabilidade da 
frequência cardíaca; Cuidados intensivos; Prognóstico
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